Korea Investment CORP Acquires 30,100 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Korea Investment CORP lifted its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 50.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 89,915 shares of the medical device company's stock after purchasing an additional 30,100 shares during the quarter. Korea Investment CORP's holdings in Cooper Companies were worth $8,266,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the stock. Raymond James Financial Inc. purchased a new position in shares of Cooper Companies during the 4th quarter valued at $64,826,000. Victory Capital Management Inc. boosted its stake in Cooper Companies by 14.6% during the fourth quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company's stock valued at $415,985,000 after buying an additional 574,899 shares during the period. JPMorgan Chase & Co. grew its position in Cooper Companies by 13.2% during the third quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company's stock worth $543,979,000 after buying an additional 573,908 shares in the last quarter. Wealthfront Advisers LLC increased its stake in Cooper Companies by 4,594.1% in the 4th quarter. Wealthfront Advisers LLC now owns 569,812 shares of the medical device company's stock worth $52,383,000 after acquiring an additional 557,673 shares during the last quarter. Finally, Alecta Tjanstepension Omsesidigt purchased a new stake in shares of Cooper Companies in the 4th quarter valued at about $49,550,000. Hedge funds and other institutional investors own 24.39% of the company's stock.

Analyst Upgrades and Downgrades

COO has been the topic of several research analyst reports. Wells Fargo & Company upped their price objective on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an "overweight" rating in a research report on Friday, December 6th. JPMorgan Chase & Co. decreased their price target on shares of Cooper Companies from $120.00 to $110.00 and set an "overweight" rating on the stock in a report on Friday, March 7th. Citigroup lowered their price objective on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a research report on Friday, March 7th. Stifel Nicolaus reduced their target price on Cooper Companies from $115.00 to $105.00 and set a "buy" rating on the stock in a research note on Friday, March 7th. Finally, StockNews.com lowered Cooper Companies from a "buy" rating to a "hold" rating in a research note on Wednesday, December 11th. Four research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $110.25.

Cooper Companies Trading Down 5.6 %

Shares of COO traded down $4.40 during trading hours on Friday, hitting $73.77. The company had a trading volume of 2,661,526 shares, compared to its average volume of 1,367,710. The Cooper Companies, Inc. has a 52-week low of $73.34 and a 52-week high of $112.38. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The stock's 50 day moving average price is $87.76 and its 200 day moving average price is $96.24. The firm has a market cap of $14.75 billion, a P/E ratio of 37.83, a P/E/G ratio of 2.25 and a beta of 1.01.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, meeting the consensus estimate of $0.92. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The firm had revenue of $964.70 million during the quarter, compared to the consensus estimate of $981.25 million. On average, research analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.